<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="134672">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02155179</url>
  </required_header>
  <id_info>
    <org_study_id>semen-esd</org_study_id>
    <nct_id>NCT02155179</nct_id>
  </id_info>
  <brief_title>Sperm Pathology Samples and Morphokinetics</brief_title>
  <official_title>Embryo Kinetics and Sperm Quality. Depends on the Sperm Quality the Embryo Cleavage Rate?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IVI Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IVI Madrid</source>
  <oversight_info>
    <authority>Spain: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The embryo kinetics may be a new prognostic factor for choosing the embryos with the highest
      implantation potential. In order to identify the factors that may affect the rate of embryo
      cleavage, there are many studies about morphokinetics and culture medium, oxygen tension,
      oocyte quality or type of medication used for ovarian stimulation. However there are no
      published data with respect to the influence of semen quality in the embryo kinetic.

      In this study The investigators propose that the sperm quality may has influence in the
      embryo division.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>embryo division in 2, 3, 4, 5, 6, 7, 8, cells and blastocyst formation</measure>
    <time_frame>between day 0 and day 5 of development</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cylindrical Embryo</condition>
  <condition>Oligospermia</condition>
  <arm_group>
    <arm_group_label>Good prognosis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>bad prognosis</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Sperms samples of assisted reproduction treatments
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sperm samples with more than 15 mill/ml of sperms, more than 40% of mobile sperms

          -  Sperm samples with less than 5 mill/ml of sperms, less than 10% of mobile sperms

        Exclusion Criteria:

          -  sperm samples between 5 to 15 mil/ml of sperms and between 10% to 40% of mobile
             sperms
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>IVI MAdrid</name>
      <address>
        <city>Madrid</city>
        <zip>28023</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>David Agudo, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 3, 2014</lastchanged_date>
  <firstreceived_date>June 2, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Oligospermia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
